Daniel Claudio de Oliveira Gomes

Title: Post Doc (UCL, Reino Unido, 2009)

Research groups: CNPq (Google Translator version)
Curriculum: Lattes
Contact

Participation in projects:

Title	Starting date	Deadline (months)	Participation in the project
Blocking of Sestrins, PD-1 and p38 MAP kinase signalling to enhance anti-Leishmania specific immunity in humans	01/07/2018	60	Coordinator *
	22/05/2017	48	Coordinator *
	22/05/2017	48	Coordinator *
	01/10/2016	24	Coordinator *
	03/06/2013	24	Coordinator *

Pages

Participants in examination boards:

Title	Name	Defense date	Course
Antigen characterization and production of antipeptide antibodies against dengue, Zika and chikungunya virus	Rafaela Spessemille Valotto	07/10/2021	M.Sc. in Biotechnology
Phenotypic and Molecular ASPECTS of Staphylococcus aureus Isolated from Maxillofacial Bone Infection	Dalliane Oliveira Soares	21/12/2020	M.Sc. in Biotechnology
DEVELOPMENT OF DECLELLULARIZED FRAMEWORK FOR use in Splenic Tissue Bioengineering	Tadeu Ériton Caliman Zanardo	27/03/2020	PhD in Biotechnology
STUDY of the Tumor Microenvironment in Carcinoma Oral and Oropharyngeal epidermoid and Its Implication prognosis	Camila Batista Daniel	12/02/2020	M.Sc. in Biotechnology
USE OF ADJUVANTS (CAF 09, CAF 01 AND MPL) MUCOSA-COMPATIBLE IN THE FORMULATION OF VACCINES AGAINST VICERAL LEISHMANIOSIS.	Andres Felipe Mendez Corea	29/03/2018	M.Sc. in Biotechnology

Pages

Disciplines taught:

Academic term	Code	Name	Hours	Course
2014/2	PBIO-040	DOUT - Biotechnical Applications of Physical-Chemical Analysis	60	PhD in Biotechnology
2014/1	PBIO-0001	Advances in Molecular and Cellular Biology	60	M.Sc. in Biotechnology

Guided Students:

Name	Title	Defense date	Role	Type
Andres Felipe Mendez Corea	USE OF ADJUVANTS (CAF 09, CAF 01 AND MPL) MUCOSA-COMPATIBLE IN THE FORMULATION OF VACCINES AGAINST VICERAL LEISHMANIOSIS.	29/03/2018	Advisor *	MSc dissertation
Divan Henrique Fernandes Barcelos	EVALUATION OF Bacteriocin Leishmanicide Potential	21/03/2018	Advisor *	MSc dissertation
Emmanoel Loss Dias	Evaluation of the Role of the Tlr1 / 2 Agonist (pam3csk4) in Potentiating the Protective Effect of Laag Vaccine Administered Via Intranasal Against Visceral Murine Leishmaniasis.	05/09/2016	Advisor *	MSc dissertation
Estevão Carlos Silva Barcelos	EVALUATION OF RESVERATROL THERAPEUTIC POTENTIAL LIKE A NEW DRUG AGAINST VISCERAL LEISHMANIOSIS	04/03/2016	Advisor *	MSc dissertation
Nataly Pescinalli Stegmiller	Comparison Between the Intranasal and Intramuscular Routes for Immunization With a Staphylococcus Aureus Gross Antigen Vaccine	30/04/2014	Advisor *	MSc dissertation